30 related articles for article (PubMed ID: 7519626)
1. Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasma.
Kirstein LM; Mellors JW; Rinaldo CR; Margolick JB; Giorgi JV; Phair JP; Dietz E; Gupta P; Sherlock CH; Hogg R; Montaner JS; Muñoz A
J Clin Microbiol; 1999 Aug; 37(8):2428-33. PubMed ID: 10405379
[TBL] [Abstract][Full Text] [Related]
2. Endogenous LINE-1 (Long Interspersed Nuclear Element-1) Reverse Transcriptase Activity in Platelets Controls Translational Events Through RNA-DNA Hybrids.
Schwertz H; Rowley JW; Schumann GG; Thorack U; Campbell RA; Manne BK; Zimmerman GA; Weyrich AS; Rondina MT
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):801-815. PubMed ID: 29301786
[TBL] [Abstract][Full Text] [Related]
3. Improved Mg2+-based reverse transcriptase assay for detection of primate retroviruses.
Sears JF; Repaske R; Khan AS
J Clin Microbiol; 1999 Jun; 37(6):1704-8. PubMed ID: 10325311
[TBL] [Abstract][Full Text] [Related]
4. Host SAMHD1 protein restricts endogenous reverse transcription of HIV-1 in nondividing macrophages.
Mahboubi B; Gavegnano C; Kim DH; Schinazi RF; Kim B
Retrovirology; 2018 Oct; 15(1):69. PubMed ID: 30316304
[TBL] [Abstract][Full Text] [Related]
5. A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivity.
Mulder J; Resnick R; Saget B; Scheibel S; Herman S; Payne H; Harrigan R; Kwok S
J Clin Microbiol; 1997 May; 35(5):1278-80. PubMed ID: 9114426
[TBL] [Abstract][Full Text] [Related]
6. Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.
Clementi M; Menzo S; Bagnarelli P; Valenza A; Paolucci S; Sampaolesi R; Manzin A; Varaldo PE
Clin Microbiol Rev; 1996 Apr; 9(2):135-47. PubMed ID: 8964032
[No Abstract] [Full Text] [Related]
7. Polymerase chain reaction (PCR) as a diagnostic tool in HIV infection.
Vandamme AM
Verh K Acad Geneeskd Belg; 1994; 56(3):231-65. PubMed ID: 7519811
[TBL] [Abstract][Full Text] [Related]
8. The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors.
Emini EA; Byrnes VW; Condra JH; Schleif WA; Sardana VV
Arch Virol Suppl; 1994; 9():11-7. PubMed ID: 7518271
[TBL] [Abstract][Full Text] [Related]
9. A rapid phenotypic assay for detecting multiple nucleoside analogue reverse transcriptase inhibitor-resistant HIV-1 in plasma.
Qari SH; Winters M; Vandamme AM; Merigan T; Heneine W
Antivir Ther; 2002 Jun; 7(2):131-9. PubMed ID: 12212925
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcription by 2',3'-dideoxynucleoside 5'-triphosphate, tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thion e, and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives.
Debyser Z; Vandamme AM; Pauwels R; Baba M; Desmyter J; De Clercq E
J Biol Chem; 1992 Jun; 267(17):11769-76. PubMed ID: 1376311
[TBL] [Abstract][Full Text] [Related]
11. Interactions of the HIV-1 reverse transcriptase 'AZT-resistant' mutant with substrates and AZT-TP.
Pokholok DK; Gudima SO; Yesipov DS; Dobrynin VN; Rechinsky VO; Kochetkov SN
FEBS Lett; 1993 Jul; 325(3):237-41. PubMed ID: 7686510
[TBL] [Abstract][Full Text] [Related]
12. A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5, 1- jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150).
Mellors JW; Im GJ; Tramontano E; Winkler SR; Medina DJ; Dutschman GE; Bazmi HZ; Piras G; Gonzalez CJ; Cheng YC
Mol Pharmacol; 1993 Jan; 43(1):11-6. PubMed ID: 7678690
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the reverse transcriptase of human immunodeficiency virus type 1 with DNA.
Bakhanashvili M; Hizi A
Biochemistry; 1994 Oct; 33(40):12222-8. PubMed ID: 7522556
[TBL] [Abstract][Full Text] [Related]
14. Development of an assay that detects transcriptionally competent human immunodeficiency virus type one particles.
Busso M; Resnick L
J Virol Methods; 1994 Apr; 47(1-2):129-39. PubMed ID: 7519626
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
